DK1015586T3 - TIE-receptortyrosinkinaseligandhomologer - Google Patents

TIE-receptortyrosinkinaseligandhomologer

Info

Publication number
DK1015586T3
DK1015586T3 DK98946988T DK98946988T DK1015586T3 DK 1015586 T3 DK1015586 T3 DK 1015586T3 DK 98946988 T DK98946988 T DK 98946988T DK 98946988 T DK98946988 T DK 98946988T DK 1015586 T3 DK1015586 T3 DK 1015586T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
receptortyrosinkinaseligandhomologer
tie
acid molecules
fls139
Prior art date
Application number
DK98946988T
Other languages
Danish (da)
English (en)
Inventor
Sherman Fong
Audrey Goddard
Paul J Godowski
Austin L Gurney
P Mickey Williams
Napoleone Ferrara
Kenneth Hillan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1015586T3 publication Critical patent/DK1015586T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98946988T 1997-09-19 1998-09-14 TIE-receptortyrosinkinaseligandhomologer DK1015586T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/934,494 US6030831A (en) 1997-09-19 1997-09-19 Tie ligand homologues

Publications (1)

Publication Number Publication Date
DK1015586T3 true DK1015586T3 (da) 2006-07-03

Family

ID=25465645

Family Applications (3)

Application Number Title Priority Date Filing Date
DK04012204T DK1482041T3 (da) 1997-09-19 1998-09-14 NL6-TIE-receptor-tyrosinkinase-ligand-homolog
DK98946988T DK1015586T3 (da) 1997-09-19 1998-09-14 TIE-receptortyrosinkinaseligandhomologer
DK04012203T DK1482040T3 (da) 1997-09-19 1998-09-14 NL3-TIE-receptortyrosinkinaseligandhomologer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04012204T DK1482041T3 (da) 1997-09-19 1998-09-14 NL6-TIE-receptor-tyrosinkinase-ligand-homolog

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04012203T DK1482040T3 (da) 1997-09-19 1998-09-14 NL3-TIE-receptortyrosinkinaseligandhomologer

Country Status (16)

Country Link
US (3) US6030831A (fr)
EP (3) EP1482040B1 (fr)
JP (3) JP3668795B2 (fr)
KR (3) KR100472262B1 (fr)
AT (3) ATE329028T1 (fr)
AU (1) AU744285B2 (fr)
CA (1) CA2304810C (fr)
CY (1) CY1105248T1 (fr)
DE (3) DE69840966D1 (fr)
DK (3) DK1482041T3 (fr)
ES (2) ES2268538T3 (fr)
IL (3) IL134647A0 (fr)
NZ (1) NZ502945A (fr)
PT (2) PT1482040E (fr)
WO (1) WO1999015654A2 (fr)
ZA (1) ZA988392B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US20030082540A1 (en) * 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
WO1999032515A2 (fr) * 1997-12-19 1999-07-01 Zymogenetics, Inc. Homologue de l'angiopoietine, adn le codant et procede de production dudit homologue
US6706869B1 (en) * 1998-02-11 2004-03-16 Wyeth Map kinase phosphatases and polynucleotides encoding them
WO1999045135A1 (fr) * 1998-03-02 1999-09-10 Millennium Pharmaceuticals, Inc. Nouvelles molecules fdrg de proteines et d'acide nucleique et utilisation desdites molecules
US20030099994A1 (en) * 1998-03-02 2003-05-29 Millennium Pharamceuticals, Inc. Novel FDRG protein and nucleic acid molecules and uses therefor
AU3661199A (en) * 1998-04-27 1999-11-16 Zymogenetics Inc. Novel polypeptide growth factors and materials and methods for making them
SV1999000069A (es) * 1998-06-02 2000-04-11 Lilly Co Eli Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
AU4643699A (en) * 1998-06-24 2000-01-10 Compugen Ltd. Angiopoietin-like growth factor sequences
US7488590B2 (en) * 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
EP1141284A2 (fr) * 1998-12-22 2001-10-10 Genentech, Inc. Methodes permettant d'inhiber la croissance de cellules neoplasiques
CA2361849A1 (fr) * 1999-03-08 2000-09-14 Genentech, Inc. Activation et inhibition de l'angiogenese et de la cardiovascularisation
DK1632499T3 (da) * 1999-03-08 2007-10-01 Genentech Inc Gensekvenser amplificeret i tumorer og diagnistiske anvendelser deraf
DE60011612T2 (de) 1999-04-28 2005-07-07 Board of Regents, The University of Texas System, Austin Zusammensetzungen und Verfahren zur Krebsbehandlung durch die selektive Hemmung von VEGF
US6703020B1 (en) 1999-04-28 2004-03-09 Board Of Regents, The University Of Texas System Antibody conjugate methods for selectively inhibiting VEGF
AU5979300A (en) * 1999-07-02 2001-01-22 Bayer Aktiengesellschaft Angiopoietin-6 and uses thereof
EP1210363A2 (fr) * 1999-07-16 2002-06-05 Hyseq, Inc. Nouveaux procedes et materiaux des angiopoietines
CA2375458A1 (fr) * 1999-07-20 2001-01-25 Genentech, Inc. Compositions et methodes pour traiter des maladies d'ordre immunologique
EP1196576A2 (fr) * 1999-07-20 2002-04-17 Curagen Corporation Polypeptides secretes et polynucleotides correspondants
EP1484401A1 (fr) * 1999-07-20 2004-12-08 Curagen Corporation Protéines secrètées et polynicleotides correspondant
US7001766B2 (en) * 1999-07-20 2006-02-21 Curagen Corporation Nucleic acid sequences encoding human angiopoietin-like polypeptides
EP1239050A4 (fr) * 1999-12-09 2004-07-21 Sankyo Co Procede d'essai d'agent curatif ou preventif de l'hyperlipemie
AU2001244509A1 (en) * 2000-03-30 2001-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treatment of conditions involving obstruction of blood flow
US20060073549A1 (en) * 2000-09-05 2006-04-06 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7238813B2 (en) * 2000-11-29 2007-07-03 Smithkline Beecham Corporation Chemical compounds
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7138370B2 (en) * 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
WO2003062373A2 (fr) * 2001-10-18 2003-07-31 The Children's Hospital Of Philadelphia Methodes et materiels de recrutement de cellules endotheliales
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20040067882A1 (en) * 2001-10-22 2004-04-08 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
IL161542A0 (en) * 2001-11-16 2004-09-27 Genentech Inc Composition comprising and method of using angiopoietin-like protein 3 angplt3
WO2003048185A2 (fr) * 2001-11-30 2003-06-12 Genvec, Inc. Facteurs associes a l'angiopoietine
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
GB0423554D0 (en) * 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
WO2006066071A2 (fr) * 2004-12-17 2006-06-22 Mayo Foundation For Medical Education And Research Pronostic du carcinome a cellules renales
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
AU2007245495A1 (en) 2006-04-26 2007-11-08 Astex Therapeutics Limited Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
JP5484063B2 (ja) * 2006-12-08 2014-05-07 レキシコン ファーマシューティカルズ インコーポレーテッド Ａｎｇｐｔｌ３に対するモノクローナル抗体
AU2008337286B2 (en) * 2007-12-19 2014-08-07 Cancer Research Technology Limited Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
GB0807609D0 (en) * 2008-04-25 2008-06-04 Cancer Rec Tech Ltd Therapeutic compounds and their use
ES2469367T3 (es) 2010-02-01 2014-06-18 Cancer Research Technology Limited 1-(5-Terc-butil-2-fenil-2H-pirazol-3-il)-3-[2-fluoro-4-(1-metil-2-oxo-2,3-dihidro-1H-imidazo[4,5-b]piridin-7-iloxi)-fenil]-urea y compuestos relacionados y su uso en terapia
AR087329A1 (es) 2011-06-17 2014-03-19 Regeneron Pharma Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis
US9988443B2 (en) 2014-08-07 2018-06-05 Novartis Ag Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
SG10201805646WA (en) 2014-08-07 2018-08-30 Novartis Ag Angiopoietin-like 4 antibodies and methods of use
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229495A (en) * 1991-06-18 1993-07-20 Ludwig Institute For Cancer Research Substantially pure receptor like TGF-β 1 binding molecules and uses thereof
JPH07506242A (ja) * 1992-01-09 1995-07-13 ヘルシンキ　ユニバーシティ　ホルディング　リミテッド Ｔｉｅ，新規内皮細胞受容体チロシンキナーゼ
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
AU4651893A (en) * 1992-06-26 1994-01-24 Immunex Corporation Novel tyrosine kinase
WO1995013387A1 (fr) * 1993-11-12 1995-05-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Nouvelle tyrosine-kinase receptrice appelee tie-2
US5643755A (en) * 1994-10-07 1997-07-01 Regeneron Pharmaceuticals Inc. Nucleic acid encoding tie-2 ligand
AUPM379494A0 (en) * 1994-02-10 1994-03-03 Ludwig Institute For Cancer Research Immunointeractive molecules - ii
WO1996009381A1 (fr) * 1994-09-22 1996-03-28 Helsinki University Licensing Ltd. Oy Promoteur pour la tyrosine-kinase receptrice tie
US5814464A (en) * 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
US5650490A (en) * 1994-10-07 1997-07-22 Regeneron Pharmaceuticals, Inc. Tie-2 ligand 2
DE69633121T2 (de) * 1995-04-06 2005-07-28 Regeneron Pharmaceuticals, Inc. Tie-2 liganden, herstellungsverfahren und verwendung
IL127623A0 (en) * 1996-06-19 1999-10-28 Regeneron Pharma Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses
US6265564B1 (en) * 1996-08-02 2001-07-24 Regeneron Pharmaceuticals, Inc. Expressed ligand-vascular intercellular signalling molecule
US5972338A (en) * 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
AU3661199A (en) * 1998-04-27 1999-11-16 Zymogenetics Inc. Novel polypeptide growth factors and materials and methods for making them
SV1999000069A (es) * 1998-06-02 2000-04-11 Lilly Co Eli Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
AU4643699A (en) * 1998-06-24 2000-01-10 Compugen Ltd. Angiopoietin-like growth factor sequences

Also Published As

Publication number Publication date
IL187847A0 (en) 2008-03-20
DK1482040T3 (da) 2006-10-02
NZ502945A (en) 2001-11-30
DK1482041T3 (da) 2009-11-02
JP3668795B2 (ja) 2005-07-06
JP2001517438A (ja) 2001-10-09
DE69834852T2 (de) 2007-05-24
CY1105248T1 (el) 2010-03-03
IL187847A (en) 2011-06-30
ATE435912T1 (de) 2009-07-15
JP2005185284A (ja) 2005-07-14
JP4239018B2 (ja) 2009-03-18
PT1482040E (pt) 2006-10-31
EP1482041A1 (fr) 2004-12-01
EP1482040B1 (fr) 2006-06-07
WO1999015654A3 (fr) 1999-10-21
EP1015586A2 (fr) 2000-07-05
PT1015586E (pt) 2006-07-31
KR100467185B1 (ko) 2005-01-24
DE69834852D1 (de) 2006-07-20
US6074873A (en) 2000-06-13
AU9388198A (en) 1999-04-12
EP1482041B1 (fr) 2009-07-08
CA2304810A1 (fr) 1999-04-01
KR20040097229A (ko) 2004-11-17
US6348351B1 (en) 2002-02-19
ZA988392B (en) 2000-03-22
US6030831A (en) 2000-02-29
KR20010024143A (ko) 2001-03-26
KR20040097230A (ko) 2004-11-17
CA2304810C (fr) 2011-05-10
JP2005176848A (ja) 2005-07-07
ATE318905T1 (de) 2006-03-15
WO1999015654A2 (fr) 1999-04-01
KR100467186B1 (ko) 2005-01-24
IL177638A0 (en) 2006-12-31
EP1482040A3 (fr) 2004-12-08
KR100472262B1 (ko) 2005-03-07
DE69833670D1 (de) 2006-04-27
EP1482040A2 (fr) 2004-12-01
ES2268538T3 (es) 2007-03-16
AU744285B2 (en) 2002-02-21
ATE329028T1 (de) 2006-06-15
ES2260848T3 (es) 2006-11-01
DE69840966D1 (de) 2009-08-20
IL134647A0 (en) 2001-04-30
DE69833670T2 (de) 2006-09-21
EP1015586B1 (fr) 2006-03-01

Similar Documents

Publication Publication Date Title
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
ATE327329T1 (de) Tie ligand-homologuen
DK0765394T3 (da) Oprensede Myceliopthora-laccaser og nukleinsyrer der koder for disse
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
ATE196164T1 (de) Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend
IL150168A0 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
DK1095140T3 (da) Neurotrofe faktorer
ATE223488T1 (de) Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren
IL180967A0 (en) Human toll homologues
ATE394484T1 (de) Smad 6 und dessen anwendungen
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE69942861D1 (de) Ldcam genannte moleküle
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
DK1082423T3 (da) Cyclin E2-gener og -proteiner
EA200100110A1 (ru) Нейротрофические факторы